EIF3I and central nervous system cancer: In the CGGA dataset, the expression of eIF3i was significantly increased along with the increasing WHO grades (both P < 0.0001, Fig. 3b), and the expression of eIF3i was also significantly (P < 0.0001) increased in IDH-wildtype gliomas (Fig. 3c).